Selection of Key Socio-Economic Factors for Establishing Relese Criteria Patients after Radioioidine Therapy

Author:

Glotova I. V.1,Trukhin A. A.2,Ryzhov S. A.3,Kiselev K. D.1

Affiliation:

1. Dmitry Rigachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology; National Research Nuclear University "MEPhI"

2. National Research Nuclear University "MEPhI"; National Medical Research Center for Endocrinology

3. Dmitry Rigachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology; Assiciation of Medical Physicists of Russia; Scientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies

Abstract

Purpose: To assess the association between socioeconomic factors and release criteria after iodine-131 radionuclide therapy in different countries. Material and methods: 15 countries and 104 socioeconomic characteristics were selected for the study. The association between characteristics and the residual activity level at which a patient may be released for different countries was established according to the value of Pearson product moment correlation coefficient (r>0.3). A linear regression model was constructed for the selected characteristics using Microsoft Excel analysis package. The model was used to calculate the acceptable activity level at which a patient may be released for Russia. Results: A fundamental difference between the model used for calculation of release criteria after radionuclide therapy with iodine-131 in Russia and the model recommended by the Nuclear Regulatory Commission was shown: the use of the effective half-life in the second one. Replacing the physical halflife by the effective half life allows increasing the discharge criteria of patients after therapy with Na131I by 30 %. A moderate correlation was found between the value of acceptable activity at patient discharge after radioactive iodine therapy and the following socioeconomic characteristics: scientific activity (r=0.32), quality of higher education (r=0.36), Global Health Security Index (r=0.34), length of roads (r=0.36), population growth rate (r=0.36), average housing area (r=0.38), and average salary per year (r=–0.33). A linear regression was constructed using the factors listed above. The following recommended value of activity and effective dose rate at patient discharge from hospital was obtained: 0.6 GBq and 30 µSv/hour. Conclusion: The study demonstrates that the release criteria for radioactive iodine therapy used in the Russian Federation (0.4 GBq and 20 µSv/h) do not correspond to the standard of living achieved in Russia, which is reflected by the socio-economic factors considered in the paper. The proposed arguments raise the task of revising the currently used model with a consequent increase in the discharge criteria. It was observed that the release criteria in the world are independent of some factors that are directly related to population exposure. The need to develop a unified objective algorithm for establishing release criteria, which takes into account different socio-economic status of states and can be applied for different radionuclides and radiopharmaceuticals, including innovative ones, has been identified.

Publisher

Association of Medical Physicists in Russia

Reference21 articles.

1. ICRP, 1991. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1-3).

2. International Atomic Energy Agency. Radiation protection and safety of radiation sources: international basic safety standards. Interim edition. Safety Standards Series No. GSR Part 3 (interim). IAEA, Vienna (2011).

3. IAEA, Release of Patients After Radionuclide Therapy, IAEA Safety report series No. 63, IAEA, Vienna. 2018.

4. NUCLEAR REGULATORY COMMISSION, Regulatory analysis on criteria for the release of patients administered radioactive material. Final report Schneider, S.; McGuire, S.A. Nuclear Regulatory Commission, Washington, DC (United States). Div. of Regulatory Applications. Funding organization: Nuclear Regulatory Commission, Washington, DC (United States).

5. National Council on Radiation Protection and Measurements (NCRP), 155 Report No. 155 – Management of Radionuclide Therapy Patients (2006).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3